ARCHIVES

FDA Approves Ribavirin Phase 102 Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 42 | October 30, 1987

Download PDF Visit The Full Archive

Related Articles

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

September 4, 1992

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

New Jersey Center Takes Slice of DOE Budget for Cancer

January 8, 1988

Community Assn. Plan Meeting In DC On Program Problems

November 29, 1974

In Brief: Last Bit of Nonsense By Weinberger; Magnuson May Write NCI Positions Into HEW Money Bill

July 18, 1975

In Brief: White House Names Five To NCAB; Carson Chairs Nursing Foundation; NF Research Award

October 9, 1992